Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals.
West Nile virus risk assessment tool
West Nile virus (WNV) is an emerging pathogen whose ecology and epidemiology extend across multiple interfaces. As the epidemiology and transmission cycle of WNV is complex, assessing the risk of WNV being transmitted to humans is not always straightforward. Therefore, the WNV risk assessment tool has been developed to provide operational guidance in support of the risk assessment process.
Avian influenza A/H5N1: Collected risk assessments, technical guidance to public health authorities and advice to the general public
The document determines the risk to human health in Europe from highly pathogenic avian influenza viruses in birds and animals and identifies areas requiring additional scientific and public health work both as single pieces of work and for risk monitoring by ECDC and its partners.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in Spain
The present report is concerned with the events in Spain surrounding two cases of infection with Crimean-Congo Haemorrhagic Fever (CCHF) virus that emerged in the Autonomous Community of Castilla y León in August 2016.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in the Netherlands
The present report is concerned with the emerging infection of tick-borne encephalitis in the Netherlands — the two first endemic cases occurring in July 2016 — in the larger context of a widespread and increasing incidence of lyme borreliosis.
Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID-19
This document provides support to healthcare workers when managing suspected or confirmed cases of novel coronavirus 2019 (COVID-19).
Infection prevention and control for COVID-19 in healthcare settings - first update
This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control measures during the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities (LTCF). It also offers guidance on the management of specimens in laboratories in the EU/EEA.
Infection prevention and control for the care of patients with 2019-nCoV in healthcare settings
This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control measures during the management of suspected and confirmed cases of 2019-nCoV infection.
An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA
According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.
Infection prevention and control in the household management of people with suspected or confirmed coronavirus disease (COVID-19)
This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do not require hospitalisation, therefore self-isolating at home.